3-Phenyl-5-isothiazole carboxamides with potent mGluR1 antagonist activity

被引：23

作者：

Fisher, Matthew J. ^{[1
]}

Backer, Ryan T. ^{[1
]}

Barth, Vanessa N. ^{[1
]}

Garbison, Kim E. ^{[1
]}

Gruber, Joseph M. ^{[1
]}

Heinz, Beverly A. ^{[1
]}

Iyengar, Smriti ^{[1
]}

Hollinshead, Sean P. ^{[1
]}

Kingston, Anne ^{[1
]}

Kuklish, Steven L. ^{[1
]}

Li, Linglin ^{[1
]}

Nisenbaum, Eric S. ^{[1
]}

Peters, Steven C. ^{[1
]}

Phebus, Lee ^{[1
]}

Simmons, Rosa Maria A. ^{[1
]}

van der Aar, Ellen ^{[1
]}

机构：

[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2012年 / 22卷 / 07期

关键词：

mGluR1; Receptor occupancy; Formalin model; METABOTROPIC GLUTAMATE RECEPTORS; ALLOSTERIC MODULATORS; ANTISENSE KNOCKDOWN; DOPAMINE D2; OCCUPANCY; BRAIN; PAIN; EFFICACY; A-841720; MODELS;

D O I：

10.1016/j.bmcl.2012.02.003

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The disclosed 3-phenyl-5-isothiazole carboxamides are potent allosteric antagonists of mGluR1 with generally good selectivity relative to the related group 1 receptor mGluR5. Pharmacokinetic properties of a member of this series (1R,2R)-N-(3-(4-methoxyphenyl)-4-methylisothiazol-5-yl)-2-methylcyclopropanecarboxamide (14) are good, showing acceptable plasma and brain exposure after oral dosing. Oral administration of isothiazole 14 gave robust activity in the formalin model of persistent pain which correlated with CNS receptor occupancy. (C) 2012 Elsevier Ltd. All rights reserved.

引用

页码：2514 / 2517

页数：4

共 39 条

[1]

Backer R.T., 2008, [No title captured], Patent No. [WO2008/103185A2, 2008103185]

[2] Comparison of rat dopamine D2 receptor occupancy for a series of antipsychotic drugs measured using radiolabeled or nonlabeled raclopride tracer [J].

Barth, Vanessa N. ;

Chernet, Eyassu ;

Martin, Laura J. ;

Need, Anne B. ;

Rash, Karen S. ;

Morin, Michelle ;

Phebus, Lee A. .

LIFE SCIENCES, 2006, 78 (26) :3007-3012

[3] Glutamate receptors and pain [J].

Bleakman, David ;

Alt, Andrew ;

Nisenbaum, Eric S. .

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2006, 17 (05) :592-604

[4] Use of LC/MS to assess brain tracer distribution in preclinical, in vivo receptor occupancy studies: Dopamine D2, serotonin 2A and NK-1 receptors as examples [J].

Chernet, E ;

Martin, LJ ;

Li, D ;

Need, AB ;

Barth, VN ;

Rash, KS ;

Phebus, LA .

LIFE SCIENCES, 2005, 78 (04) :340-346

[5] Development of a Scalable Process for the synthesis of trans-2-Methylcyclopropanecarboxylic Acid [J].

Delhaye, Laurent ;

Stevens, Christophe ;

Merschaert, Alain ;

Delbeke, Pieter ;

Brione, Willy ;

Tilstam, Ulf ;

Borghese, Alfio ;

Geldhof, Geoffroy ;

Diker, Khalid ;

Dubois, Aurelie ;

Barberis, Mario ;

Casarubios, Luis .

ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2007, 11 (06) :1104-1111

[6] A short and efficient synthesis of (R,R)-2-methylcyclopropanecarboxylic acid [J].

Delhaye, Laurent ;

Merschaert, Alain ;

Delbeke, Pieter ;

Brione, Willy .

ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2007, 11 (04) :689-692

[7] Blockade of mGluR1 receptor results in analgesia and disruption of motor and cognitive performances: effects of A-841720, a novel non-competitive mGluR1 receptor antagonist [J].

El-Kouhen, O. ;

Lehto, S. G. ;

Pan, J. B. ;

Chang, R. ;

Baker, S. J. ;

Zhong, C. ;

Hollingsworth, P. R. ;

Mikusa, J. P. ;

Cronin, E. A. ;

Chu, K. L. ;

McGaraughty, S. P. ;

Uchic, M. E. ;

Miller, L. N. ;

Rodell, N. M. ;

Patel, M. ;

Bhatia, P. ;

Mezler, M. ;

Kolasa, T. ;

Zheng, G. Z. ;

Fox, G. B. ;

Stewart, A. O. ;

Decker, M. W. ;

Moreland, R. B. ;

Brioni, J. D. ;

Honore, P. .

BRITISH JOURNAL OF PHARMACOLOGY, 2006, 149 (06) :761-774

[8] Metabotropic Glutamate 1 Receptor: Current Concepts and Perspectives [J].

Ferraguti, Francesco ;

Crepaldi, Luca ;

Nicoletti, Ferdinando .

PHARMACOLOGICAL REVIEWS, 2008, 60 (04) :536-581

[9] Glutamate- and GABA-based CNS therapeutics [J].

Foster, AC ;

Kemp, JA .

CURRENT OPINION IN PHARMACOLOGY, 2006, 6 (01) :7-17

[10] Knockdown of spinal metabotropic glutamate receptor 1 (mGluR1) alleviates pain and restores opioid efficacy after nerve injury in rats [J].

Fundytus, ME ;

Yashpal, K ;

Chabot, JG ;

Osborne, MG ;

Lefebvre, CD ;

Dray, A ;

Henry, JL ;

Coderre, TJ .

BRITISH JOURNAL OF PHARMACOLOGY, 2001, 132 (01) :354-367

← 1 2 3 4 →